Obesity Trial, Recruiting (NCT06208345)

Obesity Trial, Recruiting NCT06208345 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06208345 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The parents or guardians taking part must speak German
Families from any ethnic background or race are welcome
The child must live in the same home as the parent or guardian who is participating
The child must have a BMI (a measure of body weight relative to height) above the 97th percentile for their age and sex, based on Swiss growth charts — meaning their weight is considered very high compared to other children of the same age and sex
The child must be attending the outpatient weight management clinic at the University Children's Hospital Bern
A parent or guardian must sign a consent form agreeing to take part

Who may not be able to join:

Children whose obesity is caused by a genetic syndrome or condition
Children with a known condition present from birth that affects their muscles, bones, heart, or lungs
Children or families already taking part in another clinical trial with similar goals

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthias V. Kopp, Prof. Dr., Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland

Phone: +41 31 66 4 13 51

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06208345

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: +41 31 66 4 13 51

More information: https://clinicaltrials.gov/study/NCT06208345

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The parents or guardians taking part must speak German
Families from any ethnic background or race are welcome
The child must live in the same home as the parent or guardian who is participating
The child must have a BMI (a measure of body weight relative to height) above the 97th percentile for their age and sex, based on Swiss growth charts — meaning their weight is considered very high compared to other children of the same age and sex
The child must be attending the outpatient weight management clinic at the University Children's Hospital Bern
A parent or guardian must sign a consent form agreeing to take part

Who may not be able to join:

Children whose obesity is caused by a genetic syndrome or condition
Children with a known condition present from birth that affects their muscles, bones, heart, or lungs
Children or families already taking part in another clinical trial with similar goals

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

16 February 2024

Est. completion

30 July 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change from baseline in TEI/TEE ratio (+22 Weeks); Change from baseline in TEI/TEE ratio (+48 weeks)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov